ICI/TKI Combo Maintains Survival Benefit in Advanced RCC
(MedPage Today) -- SAN FRANCISCO -- First-line nivolumab (Opdivo) plus cabozantinib (Cabometyx) continued to demonstrate clinically meaningful survival benefits in advanced renal cell carcinoma (RCC).
An update of the CheckMate 9ER trial, which... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 20, 2023 Category: Hematology Source Type: news
New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer New Diagnostic Imaging Agent Identifies Clear Cell Renal Cancer
Radiolabeled 89Zr-DFO-girentuximab PET/CT can accurately and noninvasively identify clear cell renal carcinoma, with minimal toxicity, say researchers reporting results from the phase 3 ZIRCON trial.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Certain pesticides linked to kidney cancer in agricultural workers
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2020/7/papers/kidney-cancer/thumb894915.jpg?itok=fVpzjugS" /><br /><p>New findings from the Agricultural Health Study suggest exposure to certain pesticides may increase risk of renal cell carcinoma.</p>
(read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news
Nivolumab or Pembrolizumab Combos in Advanced Kidney Cancer? Nivolumab or Pembrolizumab Combos in Advanced Kidney Cancer?
Immunotherapy combinations based on nivolumab entail lower costs for grade 3/4 adverse events than those using pembrolizumab, a finding that could inform treatment decisions.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
British scientists give boost to hopes of living with motor neuron disease with new kidney drugs
A trial shows that injections of a protein used to treat kidney cancer may slow MND's spread and increase survival chances by 70 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - January 7, 2023 Category: Consumer Health News Source Type: news
Episode 6: Second-Line Treatment of Renal Cell Carcinoma Episode 6: Second-Line Treatment of Renal Cell Carcinoma
Drs Sumanta Pal and Martin Voss discuss second-line treatment of renal cell carcinoma, including current studies and agents used in the refractory setting.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
How to Participate in Clinical Trials for Kidney Cancer
It is fortunate that, in a majority of cases, kidney cancer is caught before spreading to other parts of the body. For these patients, treatment usually involves a nephrectomy, which is the surgical removal of one or both of the kidneys. The goal of the surgery is to prevent the cancer from metastasizing. Unfortunately, many people who undergo a nephrectomy for high-risk disease—between 20% to 50%, according to recent estimates—will eventually go on to develop metastatic cancer.
Until recently, there wasn’t much a person’s care team could do in this situation to stop the cancer from coming back. Rel...
Source: TIME: Health - December 26, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Broncos RB, Ronnie Hillman died from rare kidney cancer that affects young black males the most
Renal Medullary Carcinoma (RMC) is a cancer that is most often strikes people aged 10 to 40 years old - a form of the disease where younger people are at a higher risk. (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2022 Category: Consumer Health News Source Type: news
Trends in Genitourinary Cancers Examined in the United States
Among non - Hispanic Whites, highest incidence rates seen in Northeast for bladder cancer, Appalachia for kidney cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 21, 2022 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Internal Medicine, Nephrology, Oncology, Urology, Journal, Source Type: news
Fast acquisition techniques cut SPECT/CT bone scan times by half
Whole-body SPECT/CT bone scan times to detect metastatic tumors in prostat...Read more on AuntMinnie.comRelated Reading:
SPECT/CT AI model predicts major adverse cardiac events
SPECT tracers go head-to-head in prostate cancer patients
SPECT/CT proves value over CT diagnosing renal cancer
SPECT/CT augmented reality may help visualize metastatic melanoma
AI can detect metastatic bone lesions on scintigraphy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 19, 2022 Category: Radiology Source Type: news
These Factors Increase the Risk of Kidney Cancer
Kidney cancer is one of the 10 most-diagnosed cancers in the United States. Like many of the other cancers on that list—including colon and rectal cancer—kidney cancer is more common now than it used to be. But unlike some others, the underlying causes of kidney cancer are often hard to discern.
For example, a significant proportion of breast cancers stem from inherited genetic mutations. But that’s not the case for kidney cancer. Just 3% to 5% of these cancers are caused by hereditary factors. “There are certain genetic conditions associated with increased risk, but the vast majority of kidney canc...
Source: TIME: Health - December 13, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Cancer healthscienceclimate Source Type: news
Call for Access to SABR for Inoperable Kidney Cancer Call for Access to SABR for Inoperable Kidney Cancer
Patients who have larger, inoperable kidney cancers and those unable to undergo surgery should be offered compassionate access to stereotactic ablative body radiotherapy (SABR), say experts.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Cryoablation More Effective for Some Early-Stage Renal Cell Carcinomas
MONDAY, Dec. 5, 2022 -- For patients with early-stage renal cell carcinoma, heat-based thermal ablation is associated with increased cancer-specific mortality with tumor size 3.1 to 4 cm, while cancer-specific mortality is similar for heat-based... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 5, 2022 Category: Pharmaceuticals Source Type: news
Hope for thousands battling kidney cancer: Study reveals existing lung drug might help fight disease
Renal cell carcinoma is one of the most common cancers in the UK and US and has a 50 per cent mortality rate - partially because most patients show no symptoms until it's at a late stage. (Source: the Mail online | Health)
Source: the Mail online | Health - November 23, 2022 Category: Consumer Health News Source Type: news
Glenmark Pharma inks settlement pact with Pfizer for cancer drug
The Mumbai-based drug maker and its US-based unit have inked a settlement pact with drug major Pfizer Inc for Axitinib Tablets (1 mg and 5 mg). Glenmark's product is the generic version of Pfizer's Inlyta tablets, used to treat kidney cancer. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 22, 2022 Category: Pharmaceuticals Source Type: news
